Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Germicides mostly stay on the skin's surface, but some penetrate deeper depending on the product used.

Compound 7p shows strong potential as an anticancer agent.

Ca 45 mainly enters rat skin and eye through biosynthesis and may be adsorbed in cartilage and glands.

A woman and her daughter had thallium poisoning from a herbal drink and rodenticide, causing hair loss and other symptoms.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

Radiation therapy with chemotherapy can cause severe, long-lasting hair loss.

Nocturnal calcium infusions improved a boy's severe rickets without causing hair loss.

PDRN helps repair tissue and improve wound healing with a high safety profile.

Iodine is absorbed by hair just below the skin surface.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Researchers developed a mouse model that successfully mimics the bladder damage seen in humans after radiation therapy.

Trace element deficiencies may contribute to diffuse alopecia.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Early diagnosis, decontamination, and supportive care are crucial for managing acute radiation syndrome.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.